Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000438250 | SCV000511427 | benign | not provided | 2016-12-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000438250 | SCV001110049 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001097729 | SCV001254037 | benign | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Genetic Services Laboratory, |
RCV001821153 | SCV002066463 | likely benign | not specified | 2017-12-26 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294327 | SCV002587608 | benign | Atypical hemolytic-uremic syndrome | 2022-07-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488868 | SCV002795408 | benign | CFHR5 deficiency | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002488868 | SCV004177506 | likely benign | CFHR5 deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000438250 | SCV005260956 | likely benign | not provided | criteria provided, single submitter | not provided |